From the miRoncol archive: This update is presented in its original historical context. Current platform and product information is available throughout the main website.
miRoncol Health is pleased to announce the appointment of Victoria Xu as its new Chief Executive Officer, effective April 2024.
As miRoncol’s first committed investor and advisor, and with a Master’s in Bioinformatics and Public Management, Victoria Xu will lead miRoncol Health’s mission to provide healthy individuals a new line of defense against cancer through real-time, blood-based multi-cancer risk assessment using microRNA (miRNA) technology. Passionate about prevention and sustainability, she champions responsible innovation that improves quality of life and planetary health.